The U.S. International Trade Commission (Commission or USITC) today determined there is a reasonable indication that a U.S. industry is materially injured due to imports of choline salts from China that are allegedly sold in the United States at less than fair value and subsidized by the government of China.

Chairman Brett W. Doyle and Commissioners David S. Johanson and Jason E. Kearns voted in the affirmative. Commissioners Amy A. Karpel and Peter-Anthony Pappas did not participate in the vote.

As a result of the Commission’s affirmative determinations, the U.S. Department of Commerce will continue its investigations of imports of this product from China.

The Commission’s public report, Choline Salts from China; Inv. Nos. 701-TA-798 and 731-TA-1794 (Preliminary), USITC Publication 5778, August 2026), will contain the views of the Commission and information developed during the investigations.

The report will be available on the USITC website by September 14, 2026.